#Cannabisstocks: Privateer Holdings Inc. Releases Statement That It Does Not Plan to Register, Sell or Distribute Its Tilray (NASDAQ: $TLRY) Shares in the First Half of 2019

(MENAFN- Investors Ideas)
#Cannabisstocks: Privateer Holdings Inc. Releases Statement That It Does Not Plan to Register, Sell or Distribute Its Tilray (NASDAQ: $TLRY) Shares in the First Half of 2019 Stock Soars - TLRY $101.4121 up $21.0121 up 26.13%

SEATTLE - January 11, 2019 (Investorideas.com Newswire) Privateer Holdings Inc. (Privateer), the world's first and leading private equity firm investing exclusively in the emerging legal cannabis industry, today issued the following statement, strongly emphasizing that it does not have plans to register, sell or distribute the 75 million shares that Privateer owns in Tilray, Inc. (TLRY) when the lock-up expires next week.

Statement from Michael Blue, Managing Partner of Privateer Holdings, in response to market speculation regarding its Tilray shareholding:

"Privateer Holdings strongly believes in Tilray's long-term global growth strategy and pioneering role in shaping the future of the legal cannabis industry. Given this, we do not have plans to register, sell or distribute the shares Privateer holds in Tilray during the first half of 2019. When we decide to distribute shares, we will do so in an orderly and deliberate manner to maximize tax-efficiency considerations for Privateer investors, while also taking into consideration potential impacts on Tilray's public float. And we will do it in a way that reflects our long-term confidence in Tilray's business model and management team."

ABOUT PRIVATEER HOLDINGS INC.

Privateer Holdings is the world's first private equity firm to invest exclusively in legal cannabis. The Privateer Holdings team has raised $200 million to invest in cannabis brands. Learn more at www.privateerholdings.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20190111005068/en/

Contact:

Privateer Holdings
Zack Hutson, +1-415-534-5541

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

MENAFN1201201901420000ID1097962697

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.